Form 4: Elanco EVP Modi adds 67 DSUs via deferral

Elanco EVP Rajeev A. Modi reported acquiring 67.0754 deferred stock units at $21.09, increasing his DSU holdings to 7,230.2452.

Summary

• Executive Vice President Rajeev A. Modi acquired 67.0754 Deferred Stock Units (DSUs) on 2025-11-14.
• Transaction coded as “A” (award/acquisition) with a reported derivative price of $21.09.
• Post-transaction, Modi beneficially owns 7,230.2452 DSUs.
• Each DSU represents the right to receive one share of common stock or the cash equivalent.
• DSUs settle in cash or shares after termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.
• No open-market purchase or sale of common stock was reported.

Sentiment

Score: 6

Explanation: Small, routine DSU acquisition that modestly improves insider alignment with minimal immediate market or financial impact.

Positives

• Increased insider alignment: DSU holdings rose to 7,230.2452 units.
• Award structure defers settlement until termination or a specified future year, promoting long-term alignment.
• No immediate cash outlay or market selling pressure associated with this award.

Negatives

• Award is part of a deferred compensation program rather than an open-market purchase, offering limited immediate signaling value.
• Future settlement in shares could incrementally dilute shareholders, though the reported 67.0754 units are immaterial in size.

Future Outlook

No guidance or forward-looking financial statements provided; the DSU award will settle after termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.

Industry Context

Routine executive DSU awards and deferral programs are common across large-cap life sciences and animal health companies, supporting long-term incentive alignment without immediate market impact.

Comparison to Industry Standards

• Executive DSU deferral structures align with standard practices at animal health peers and broader large-cap healthcare companies (e.g., use of DSUs and deferred settlement windows).
• The immaterial unit amount (67.0754) is consistent with routine periodic accruals rather than a standalone strategic grant, similar to standard deferral plan contributions observed across S&P 500 executives.
• Absence of open-market activity mirrors common compensation-driven insider transactions, which generally carry limited short-term signaling compared with discretionary insider buys.

Stakeholder Impact

• Shareholders: Minimal dilution risk from 67.0754 underlying shares; positive alignment of executive incentives.
• Employees: Reinforces long-term incentive culture via deferral and matching plan.
• Creditors: No immediate balance sheet or liquidity impact from the equity-based award.
• Market participants: Limited short-term price signaling due to compensation-driven nature of the transaction.

Next Steps

• Settlement of DSUs in cash or shares following termination of employment or in a specified future year per the Executive Deferral and Stock Match Plan.

Key Dates

Keywords

Elanco Animal Health, ELAN, insider transaction, Deferred Stock Units, executive compensation, beneficial ownership, Executive Deferral and Stock Match Plan, SEC Form 4, animal health